0

<< Alcohol Withdrawal Syndrome: Improving Outcomes Through Early Identification And Aggressive Treatment Strategies (Critical Care Issue)

Treatment

GABAA Agonists

Benzodiazepines

The cornerstone of the management of AWS is administration of sedative-hypnotic xenobiotics, most notably, benzodiazepines. The use of sedative-hypnotics in AWS is logical, given the psychomotor agitation that develops with severe symptoms. As central GABAA agonists, benzodiazepines directly address the underlying pathophysiology of the GABAA receptor driving alcohol withdrawal. A landmark study in 1969 compared chlordiazepoxide, hydroxyzine, thiamine, chlorpromazine, and placebo. Chlordiazepoxide was associated with the lowest incidence of DT and alcohol withdrawal seizures.28 Two Cochrane reviews concluded that benzodiazepines are effective in the management of alcohol withdrawal.11,12

To continue reading, please log in or purchase access.

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.